MILESTONE SCIENTIFIC INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
MLSS$0.300.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
YEARS ENDED DECEMBER 31,
| ` | 2025 | 2024 |
|---|---|---|
| Product sales, net | $8,973,982 | $8,629,928 |
| Cost of products sold | 2,566,405 | 2,195,340 |
| Gross profit | 6,407,577 | 6,434,588 |
| Selling, general and administrative expenses | 11,576,530 | 12,295,330 |
| Research and development expenses | 449,469 | 858,767 |
| Depreciation and amortization expense | 78,195 | 37,448 |
| Total operating expenses | 12,104,194 | 13,191,545 |
| Loss from operations | (5,696,617) | (6,756,957) |
| Interest (expense) income, net | (25,599) | 60,265 |
| Gain on sale of net operating losses | - | 1,983,095 |
| Loss before provision for income taxes | (5,722,216) | (4,713,597) |
| Provision for income taxes | - | - |
| Net loss | $(5,722,216) | $(4,713,597) |
| Net loss per share applicable to common stockholders— | ||
| Basic and Diluted | (0.07) | (0.06) |
| Weighted average shares outstanding and to be issued— | ||
| Basic and diluted | 82,064,109 | 79,791,188 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.